DK1438341T3 - Antistoffer som stimulerer produktionen af IL-1Ra - Google Patents

Antistoffer som stimulerer produktionen af IL-1Ra

Info

Publication number
DK1438341T3
DK1438341T3 DK02793224T DK02793224T DK1438341T3 DK 1438341 T3 DK1438341 T3 DK 1438341T3 DK 02793224 T DK02793224 T DK 02793224T DK 02793224 T DK02793224 T DK 02793224T DK 1438341 T3 DK1438341 T3 DK 1438341T3
Authority
DK
Denmark
Prior art keywords
antibodies
production
stimulate
monocytes
macrophages
Prior art date
Application number
DK02793224T
Other languages
English (en)
Inventor
Martine Bruley-Rosset
Frederic Dhainaut
Dominique Bourel
Jacky Lirochon
Original Assignee
Fractionnement Et De Biotechno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fractionnement Et De Biotechno filed Critical Fractionnement Et De Biotechno
Application granted granted Critical
Publication of DK1438341T3 publication Critical patent/DK1438341T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02793224T 2001-11-09 2002-11-08 Antistoffer som stimulerer produktionen af IL-1Ra DK1438341T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0114518A FR2832155B1 (fr) 2001-11-09 2001-11-09 Anticorps stimulant la production d'il-1ra

Publications (1)

Publication Number Publication Date
DK1438341T3 true DK1438341T3 (da) 2006-06-06

Family

ID=8869239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02793224T DK1438341T3 (da) 2001-11-09 2002-11-08 Antistoffer som stimulerer produktionen af IL-1Ra

Country Status (14)

Country Link
US (1) US20050089520A1 (da)
EP (1) EP1438341B1 (da)
JP (1) JP4477874B2 (da)
AT (1) ATE319744T1 (da)
AU (1) AU2002358885B2 (da)
CA (1) CA2467853A1 (da)
CY (1) CY1105017T1 (da)
DE (1) DE60209797T2 (da)
DK (1) DK1438341T3 (da)
ES (1) ES2256579T3 (da)
FR (1) FR2832155B1 (da)
IL (2) IL161872A0 (da)
PT (1) PT1438341E (da)
WO (1) WO2003040188A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180005856A (ko) * 2016-07-07 2018-01-17 동국대학교 산학협력단 IL-1ra를 포함하는 피부 자극 물질 스크리닝용 조성물 및 이를 이용한 피부 자극 물질의 스크리닝 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19920704C1 (de) * 1999-01-26 2000-08-31 Technologie Integrale Ltd Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
FR2794460A1 (fr) * 1999-06-07 2000-12-08 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'igg humaines possedant une activite immunomodulatrice

Also Published As

Publication number Publication date
DE60209797T2 (de) 2007-01-11
CA2467853A1 (fr) 2003-05-15
FR2832155A1 (fr) 2003-05-16
ATE319744T1 (de) 2006-03-15
JP2005519027A (ja) 2005-06-30
EP1438341A1 (fr) 2004-07-21
AU2002358885B2 (en) 2009-01-08
US20050089520A1 (en) 2005-04-28
FR2832155B1 (fr) 2004-07-09
EP1438341B1 (fr) 2006-03-08
JP4477874B2 (ja) 2010-06-09
CY1105017T1 (el) 2009-11-04
PT1438341E (pt) 2006-06-30
IL161872A (en) 2009-12-24
WO2003040188A1 (fr) 2003-05-15
ES2256579T3 (es) 2006-07-16
DE60209797D1 (de) 2006-05-04
IL161872A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
NO20071740L (no) Humaniserte anti-beta7-antagonister og anvendelser derav
IS6999A (is) Mótefni sem blokka prótínið Cripto og notkun þeirra
DK1562968T3 (da) Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser
IS8451A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
NO20034056D0 (no) Proliferative sykdommer
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
NO20033418D0 (no) Immunregulatoriske antistoffer og anvendelse derav
ITMI20032448A1 (it) Protesi parietale di rinforzo e metodo di realizzazione della stessa.
CA97145S (en) Eyeglasses
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
PH12022552267A1 (en) Tie2-binding agents and methods of use
NO20044898L (no) Nye etonogestrel estere
ATE363531T1 (de) Claudin polypeptide
ITMI20021822A1 (it) Manicotto elastico e procedimento per la fabbricazione di un manicotto elastico
ES2165506T3 (es) Antagonistas del il-8 para el tratamiento del asma.
DK1438341T3 (da) Antistoffer som stimulerer produktionen af IL-1Ra
WO2001070253A8 (en) Use of mia in immunotherapy
IL177825A0 (en) Natural igm antibodies and inhibitors thereof
DE50212676D1 (de) Exopolysaccharidproduktion
EE200300377A (et) Loomulikud HI-viiruse vastased antikehad
NO20033956D0 (no) Stenter med radioaktivt belegg
IS8914A (is) Mótefni sem blokka prótínið Cripto og notkun þeirra
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih